Paper36979633
Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy.
Jung I and 2 others. Biomedicines, 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy. Papers, record 36979633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979633
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022R1I1A1A01069184 | National Research Foundation of Korea | PubMed | ||
| 2022R1F1A1066420 | National Research Foundation of Korea | PubMed | ||
| 2022R1A2C1011306 | National Research Foundation of Korea | PubMed | ||
| IBS-R022-D1 | Institute for Basic Science | PubMed |
Source PubMed
References168
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23492775 | MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. | Cell Death Dis | 2013 | https://conductscience.org/library/papers/23492775 | PubMed |
| 2 | 12011120 | Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/12011120 | PubMed |
| 3 | 31870430 | Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression. | Genome Med | 2019 | https://conductscience.org/library/papers/31870430 | PubMed |
| 4 | 30146412 | SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function. | Cell Stem Cell | 2018 | https://conductscience.org/library/papers/30146412 | PubMed |
| 5 | 19789556 | Rethinking how DNA methylation patterns are maintained. | Nat Rev Genet | 2009 | https://conductscience.org/library/papers/19789556 | PubMed |
| 6 | 33935952 | SIRT1 Deacetylates TET2 and Promotes Its Ubiquitination Degradation to Achieve Neuroprotection Against Parkinson's Disease. | Front Neurol | 2021 | https://conductscience.org/library/papers/33935952 | PubMed |
| 7 | 29511063 | Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. | J Exp Med | 2018 | https://conductscience.org/library/papers/29511063 | PubMed |
| 8 | 31911474 | High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/31911474 | PubMed |
| 9 | 15809266 | The impact of metabolism on DNA methylation. | Hum Mol Genet | 2005 | https://conductscience.org/library/papers/15809266 | PubMed |
| 10 | 34790902 | Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. | Nat Cancer | 2021 | https://conductscience.org/library/papers/34790902 | PubMed |
| 11 | 29755367 | The Transcription Factor Hif-1 Enhances the Radio-Resistance of Mouse MSCs. | Front Physiol | 2018 | https://conductscience.org/library/papers/29755367 | PubMed |
| 12 | 21892189 | The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. | Nature | 2011 | https://conductscience.org/library/papers/21892189 | PubMed |
| 13 | 28943252 | Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease. | Stem Cell Reports | 2017 | https://conductscience.org/library/papers/28943252 | PubMed |
| 14 | 19372393 | The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. | Science | 2009 | https://conductscience.org/library/papers/19372393 | PubMed |
| 15 | 8247133 | Role for DNA methylation in genomic imprinting. | Nature | 1993 | https://conductscience.org/library/papers/8247133 | PubMed |
| 16 | 26883721 | DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation. | Cancer Prev Res (Phila) | 2016 | https://conductscience.org/library/papers/26883721 | PubMed |
| 17 | 25362856 | TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway. | Oncogene | 2015 | https://conductscience.org/library/papers/25362856 | PubMed |
| 18 | 28825709 | Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. | Nature | 2017 | https://conductscience.org/library/papers/28825709 | PubMed |
| 19 | 22728050 | Ascorbic acid: chemistry, biology and the treatment of cancer. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22728050 | PubMed |
| 20 | 25822089 | Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells. | Nat Genet | 2015 | https://conductscience.org/library/papers/25822089 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42557305 | TET2-driven demethylation of ANG promotes angiogenesis and malignant transformation in oligodendroglioma. | Oncogene | 2026 | https://conductscience.org/library/papers/42557305 | PubMed |
| 42496533 | Epigenetic Mechanisms of Breast and Ovarian Cancer Development: Interplay Between DNA Methylation/Demethylation Enzymes, MicroRNAs, and Long Non-Coding RNAs. | Epigenomes | 2026 | https://conductscience.org/library/papers/42496533 | PubMed |
| 41510594 | Targeted demethylation of the BRD7 promoter based on CRISPR/dCas9 system inhibits the malignant progression of nasopharyngeal carcinoma. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/41510594 | PubMed |
| 41509068 | Synthesis, characterization, and anticancer evaluation of N-Heterocyclic entities: ADME profiling and In Silico predictions. | Toxicol Rep | 2026 | https://conductscience.org/library/papers/41509068 | PubMed |
| 41207793 | Gene Therapy for Fragile X Syndrome, Challenges, and Promises. | J Gene Med | 2025 | https://conductscience.org/library/papers/41207793 | PubMed |
| 40813509 | AKR1B10 as a novel prognostic biomarker linking methylation and immune escape in hepatocellular carcinoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40813509 | PubMed |
| 40806634 | DNA Methylation in Bladder Cancer: Diagnostic and Therapeutic Perspectives-A Narrative Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806634 | PubMed |
| 40427015 | Epigenetic Therapies in Melanoma-Targeting DNA Methylation and Histone Modification. | Biomedicines | 2025 | https://conductscience.org/library/papers/40427015 | PubMed |
| 39766901 | The Simultaneous Treatment of PC-3 Cells with the DNA-Demethylating Agent Decitabine and S-Adenosylmethionine Leads to Synergistic Anticancer Effects. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39766901 | PubMed |
| 39495308 | The implication of TET1, miR-200, and miR-494 expression with tumor formation in colorectal cancer: through targeting Wnt signaling. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/39495308 | PubMed |
| 38393645 | EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38393645 | PubMed |
| 38003566 | Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003566 | PubMed |
| 37441023 | Silencing of AJAP1 expression by promoter methylation activates the Wnt/β-catenin signaling pathway to promote tumor proliferation and metastasis in salivary adenoid cystic carcinoma. | Gland Surg | 2023 | https://conductscience.org/library/papers/37441023 | PubMed |
Genes45
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979633
GET https://conductscience.org/api/papers/v1/36979633/references?page=2